Company intelligence / Profile preview

Kardion

Ownership: Private
Development stage: Preclinical

Overview

Kardion is an innovative medical technology company specializing in the development of advanced cardiovascular devices designed to integrate seamlessly with the human body. The company emphasizes rigorous engineering, evidence-based innovation, and has a strong intellectual property position with dozens of patents related to cardiology, fluid dynamics, and cardiac implants. No clinical trial results are publicly summarized.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically cardiovascular devices)
Industry: Implantable Medical Devices

Partnerships

Revival Healthcare Capital (investor/partner)

Beyond the preview

Go deeper on Kardion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kardion.

Explore the full profile